Investment in Science for Health

Helba Pharmaceuticals has an R&D Center in its high-tech production facility, established in line with the vision of “Investing in Science for Health”.

Helba Pharma R&D Center, certified by the Ministry of Industry and Technology, has the ability to develop equivalent drugs in all non-sterile dosage forms, with the most up-to-date scientific methods, in order to respond to the changing needs of the national and international pharmaceutical industry. In the R&D center; in line with the studies in the fields of central nervous system, dermatology, gynecology, urology, gastroenterology and cardiovascular diseases, it is aimed to develop an average of 15 new products every year. In addition, Validation and Qualification studies are carried out in the Quality Control Laboratory, which has advanced technology equipment and experts work.

Know-How Transfer

In addition to the local product development projects , it is also planned to carry out know-how transfer with joint projects with domestic and international business partners and research institutions.

Innovative Products

Helba Pharma aims to develop innovative new forms and products with high added value with its expert staff and laboratories equipped with up-to-date technology and comprehensive equipment line.

R&D Center

Helba Pharma R&D Center, which has the ability to develop products in all pharmaceutical forms, will include pre-formulation and formulation development, pilot production area, analytical development laboratory and stability cabins.

Human Resources

  • Patent Scanning and Evaluation
  • Raw Material Characterization
  • Pharmaceutical Product for All Dosage Forms
  • Analytical Method Development, Optimization and Validation
  • Laboratory Scale and Scale-Up Productions
  • Process Optimization and Validation
  • Stability Studies
  • Bioequivalence and Clinical Studies
  • Technology Transfer Studies
  • And More